Combiphar has since continued to touch the lives of the Indonesian people. Today, more and more individuals and families are feeling the benefits from Combiphar’s products and healthy lifestyle educations. Today, Combiphar produces and distributes more than 80 affordable prescription and over-the-counter drugs to its consumers, including OBH Combi cough syrup and Insto eye drops. The various brands of medication produced and marketed by Combiphar each contribute an important role in their respective categories. Numerous initiatives to support various communities and professional medical practitioners have also been introduced as Combiphar’s commitment to the health of the nation.
To be the leading recognizable health care company that touches the lives of consumers by improving their individual health and community.
Strive for a better consumers’ well being through affordable quality products or services that promotes a healthy lifestyle to its fullness.
Consumer Focused Solution – Passionate – Leadership – Integrity – Innovative
Combiphar was founded in 1971 as a cottage industry, until in 1983 it expanded and established a factory on a larger scale in Padalarang.
Two important figures, which are DR. Biantoro Wanandi, Doctor of Natural Sciences from the Swiss Federal Institute of Technology in Zurich Switzerland, and Mr. Hamadi Widjaja, a graduate of INSEAD Fontainebleau in France, started a new era in Combiphar.
Built plant and joint operation with ROHTO & Sanofi Synthellabo SAP Implementation
CSR Program Launch - Combi Hope Healthy Living Education & Women’s Empowerment INSTO Brand Acquisition Combi Care Centre Launch
New Head Office Relocation and New Corporate Identity Launch
ISO 9001-2000 Certification, R & D Facilities Upgrade, Implement Lean Manufacturing
Under the wings of Anugerah Group, Combiphar collaborates with leading pharmaceutical companies in more than 19 countries. From this collaboration, Combiphar regularly carries out quality control audits, get trained and knowledge by international caliber partners to improve quality. Combiphar Entering Singapore and Malaysia. 2016, Eye Mo Acquisition from GSK. Combiphar Entering 1st international market, Philippine. 2018, Combiphar Entering Cambodia.
In 2019, Combiphar acquired Air Mancur Group to affirm the commitment of Championing a Healthy Tomorrow, by expanding the Combiphar product line to help create a healthier generation of Indonesia. Combiphar Entering Hong Kong.
Carrying out the first commercial production of INSTO eye drops from the newest factory facility in Cikarang. This factory can accommodate a production capacity of up to 50 million bottles per year and can still be expanded further. - Takeover of Shares Acquisition of Simba Indosnack Makmur
President Commissioners
Commissioners
Commissioners
Commissioners
Commissioners
President Director
Director
Director
Director
Affordable and High Quality Products
Consumer Dialogue and Engagement
Build and Educate Communities